Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.
复制标题
DOI:
10.1186/s12974-021-02204-0
复制
发表时间:
2021-07-08
影响因子:
9.3
通讯作者:
Trazzi S
中科院分区:
文献类型:
--
作者:
Galvani G;Mottolese N;Gennaccaro L;Loi M;Medici G;Tassinari M;Fuchs C;Ciani E;Trazzi S
CDKL5 deficiency disorder (CDD), a severe neurodevelopmental disorder characterized by early onset epilepsy, intellectual disability, and autistic features, is caused by mutations in the CDKL5 gene. Evidence in animal models of CDD showed that absence of CDKL5 negatively affects neuronal survival, as well as neuronal maturation and dendritic outgrowth; however, knowledge of the substrates underlying these alterations is still limited. Neuroinflammatory processes are known to contribute to neuronal dysfunction and death. Recent evidence shows a subclinical chronic inflammatory status in plasma from CDD patients. However, to date, it is unknown whether a similar inflammatory status is present in the brain of CDD patients and, if so, whether this plays a causative or exacerbating role in the pathophysiology of CDD. We evaluated microglia activation using AIF-1 immunofluorescence, proinflammatory cytokine expression, and signaling in the brain of a mouse model of CDD, the Cdkl5 KO mouse, which is characterized by an impaired survival of hippocampal neurons that worsens with age. Hippocampal neuron survival was determined by DCX, NeuN, and cleaved caspase-3 immunostaining in Cdkl5 KO mice treated with luteolin (10 mg/kg), a natural anti-inflammatory flavonoid. Since hippocampal neurons of Cdkl5 KO mice exhibit increased susceptibility to excitotoxic stress, we evaluated neuronal survival in Cdkl5 KO mice injected with NMDA (60 mg/kg) after a 7-day treatment with luteolin. We found increased microglial activation in the brain of the Cdkl5 KO mouse. We found alterations in microglial cell morphology and number, increased levels of AIF-1 and proinflammatory cytokines, and activation of STAT3 signaling. Remarkably, treatment with luteolin recovers microglia alterations as well as neuronal survival and maturation in Cdkl5 KO mice, and prevents the increase in NMDA-induced cell death in the hippocampus. Our results suggest that neuroinflammatory processes contribute to the pathogenesis of CDD and imply the potential usefulness of luteolin as a treatment option in CDD patients. The online version contains supplementary material available at 10.1186/s12974-021-02204-0.
登录
查看更多内容
影响因子:
4.6
作者:
Davis BM;Salinas-Navarro M;Cordeiro MF;Moons L;De Groef L
通讯作者:
De Groef L
影响因子:
5.6
作者:
Aronica E;Bauer S;Bozzi Y;Caleo M;Dingledine R;Gorter JA;Henshall DC;Kaufer D;Koh S;Löscher W;Louboutin JP;Mishto M;Norwood BA;Palma E;Poulter MO;Terrone G;Vezzani A;Kaminski RM
通讯作者:
Kaminski RM
影响因子:
4.8
作者:
Jin XR;Chen XS;Xiao L
通讯作者:
Xiao L
影响因子:
3
作者:
Birman, Husniye;Dar, Kadriye Akgun;Uzum, Gulay
通讯作者:
Uzum, Gulay
影响因子:
5.3
作者:
Ginhoux F;Lim S;Hoeffel G;Low D;Huber T
通讯作者:
Huber T